According to research published online January 1, 2014 in the New England Journal of Medicine, a new drug called romosozumab may offer hope for the treatment of osteoporosis. The drug works by freeing the body’s ability to stimulate bone production by blocking signals that naturally inhibit bone formation. According to
Tag: zoledronic acid
Doctors have at their disposal a broad array of arthritis medications: some fast-acting and widely used, some that run the risk of dependence. Your prescription will depend on the severity of your condition.
The first tier in the drug pharmacopeia available is called “the first line” of available arthritis medications. They’re
With up to 54 million Americans suffering from low bone density or osteoporosis, development of a new drug to combat the condition is timely. The new therapy, a dietary supplement that is a special blend of collagen and calcium, called KoACT®, in clinical trials was found superior to calcium and
The concerns of osteoporosis for women are well documented, but did you know that men are also at risk for serious fractures due to the condition? Research has shown that 1 in 4 men over the age of 50 will break a bone during his lifetime due to osteoporosis.
The bone-thinning disease osteoporosis is a concern for many women after age 50. But men can also develop osteoporosis, and there are other risk factors. For example, having rheumatoid arthritis (RA) increases risk, regardless of your age.
Our bones constantly change. In the process of bone turnover, cells called osteoclasts break
Your bones are your body’s framework—and for many, the bone-building drugs bisphosphonates ensure a sound foundation against the impact of osteoporosis. Bisphosphonates, including the oral drugs alendronate (Fosamax®), risedronate (Actonel®) and ibandronate (Boniva®), and the intravenously (IV) administered zoledronic acid (Reclast®), have been shown to reduce the risk for fracture